The 15% Yield ETF That Steals Warren Buffett's Playbook

VistaShares' Target 15 Berkshire Select Income ETF (OMAH) targets a 15% annual distribution paid monthly by combining Berkshire-style value holdings with an options overlay. The article notes OMAH returned 13% in price terms over the past year versus 0% for Berkshire, but emphasizes the payout is not guaranteed and may include return of capital and tax-inefficient income. The piece is mainly an investor education/strategy comparison rather than a catalyst for a broad market move.

Analysis

OMAH is less a dividend product than a volatility monetization vehicle wrapped around a quality-factor sleeve. The key second-order effect is that the basket’s real economic driver is not the cash yield of KO/AXP/BAC/CVX, but the dispersion between their idiosyncratic upside and the call premium the fund can harvest; in a choppy, range-bound tape, that spread can support the distribution without destroying NAV. That makes the fund structurally more attractive when realized vol stays elevated but directional trend is muted, and much less attractive if rates fall and the market re-rates quality cyclicals upward.

The biggest hidden risk is regime shift: if the market rotates back to a broad multiple expansion led by mega-cap growth or if Berkshire itself reaccelerates, OMAH’s capped convexity turns from a feature into a tax on performance. In that scenario, the opportunity cost is not just missed upside; it is the compounding you forfeit by surrendering the right tail in names that can still produce multi-year total return. The fund’s monthly payout can also become a behavioral trap, attracting yield-seeking capital right before a drawdown because the distribution masks NAV leakage.

From a factor perspective, this is effectively long value/quality, short upside convexity, and implicitly short duration in the sense that it benefits from near-term cash generation more than long-horizon compounding. The per-ticker sentiment skew suggests KO/CVX are the cleaner expressions of the thesis: defensive cash flow plus lower beta, while BAC and AXP add more cyclical sensitivity and higher sensitivity to rate expectations and credit conditions. The cleanest read-through is that the product should hold up best when rates remain range-bound and equity markets churn, but should underperform a reflationary melt-up or a sharp recessionary selloff.

Consensus is likely underestimating how much the distribution target depends on realized volatility staying supportive. The 15% headline yield looks attractive, but in a low-vol environment the fund may be forced to source more return of capital, making the apparent income partially a capital return disguise. The market is paying for cash flow visibility, but the true underwriting question is whether investors are being compensated enough for giving up Berkshire-like compounding in exchange for a monthly paycheck.

Key Decisions for Investors

• Overweight OMAH only as a 5%-10% income sleeve in retirement accounts over the next 1-3 months; expected upside is modest but income is well-supported if equities stay range-bound, while downside is capped only on the upside, not on NAV.
• Pair trade: long OMAH / short BRK.B over the next 6-12 months if your view is sideways-to-slightly-up markets and persistently elevated realized vol; this isolates income extraction versus pure compounding and should outperform in choppy tape, but monitor for a broad risk-on melt-up.
• Prefer KO and CVX over BAC and AXP as the core equity exposure if the goal is cash flow with lower drawdown risk; KO/CVX offer more defensive earnings visibility, while BAC/AXP are more exposed to rates and credit cycle reversal.
• Do not buy OMAH in taxable accounts unless the holding period is tactical and under 12 months; the monthly distribution structure and ROC risk create avoidable tax drag relative to owning BRK.B or a plain dividend ETF.
• If the S&P 500 breaks into a sustained 10%+ rally led by growth, reduce or hedge OMAH immediately via index calls or by switching to BRK.B; the fund’s capped upside will likely underperform by enough to justify taking profit early.